Mpox no longer an international health emergency, says WHO chief
September 5, 2025
The World Health Organization has declared that mpox no longer represents a Public Health Emergency of International Concern, marking a major milestone in the global response. Sustained declines in cases in the Democratic Republic of the Congo, Burundi, Sierra Leone, and Uganda informed this decision. While the announcement reflects clear progress, it should not be mistaken for eradication. Mpox continues to pose risks in vulnerable populations and under-resourced areas. The decision underscores the value of international cooperation and targeted interventions, while reminding the global community that vigilance, investment in surveillance, and equitable vaccine access remain essential to prevent resurgence.
The announcement by the World Health Organization that mpox is no longer considered a Public Health Emergency of International Concern represents a turning point in the management of this once-urgent crisis. The decision, endorsed by the WHO Emergency Committee, reflects sustained declines in case numbers across the most heavily affected countries, including the Democratic Republic of the Congo, Burundi, Sierra Leone, and Uganda. It is both a recognition of progress made and a reminder of the importance of coordinated global health action.
Mpox, a viral infection that spreads through close contact and often causes flu-like symptoms and distinctive lesions, surged across parts of Africa beginning in 2024. At its peak, the outbreak prompted WHO to raise its highest alert level, a designation that brought international attention, funding, and response coordination. Local and regional measures, ranging from vaccination campaigns to community engagement and surveillance enhancements, were instrumental in driving down cases and saving lives.
However, declaring an end to the international emergency does not mean the disease has been eliminated or that the risk has vanished. Mpox remains endemic in parts of Africa, and vulnerable groups, such as immunocompromised individuals, children, and healthcare workers, continue to face heightened risks. The global health community must remain attentive to local outbreaks, ensure vaccines and treatments are accessible, and support countries with weaker health infrastructures.
The lifting of the emergency status signals progress but also calls for sustained commitment. If anything, it demonstrates that investment in surveillance, rapid response, and community trust can turn the tide against an epidemic. The global community must carry forward these lessons to strengthen preparedness for mpox and other emerging infectious threats.